Buy XTL Biopharmaceuticals Stock | XTLB Stock Price & Latest News | Public.com
XTLB

XTL Biopharmaceuticals

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View XTL Biopharmaceuticals (XTLB) stock trends here

    About XTLB

    XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its pipeline includes hCDR1 and Erythropoietin. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel. T...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Stats

    Market Cap$17.85M
    Volume228
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$6.11
    1 Year Low$1.12
    Open$3.36
    High$3.36
    Low$3.36

    Buy any stock with any amount of money.

    Download the App
    Download the app